Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Biorce’s Aika represents a groundbreaking AI-driven clinical intelligence platform that enhances every phase of the clinical trial lifecycle by transforming slow, manual processes for protocol development and feasibility assessments into efficient, evidence-based automation. Leveraging insights from approximately one million real-world trials, Aika can swiftly produce first-draft study protocols, comprehensive regulatory documentation, site feasibility evaluations, risk management strategies, and other critical trial components significantly faster than conventional approaches, which helps in minimizing delays and expensive modifications. Aika not only ensures complete transparency in its recommendation processes, allowing teams to confidently communicate their decisions to regulators while retaining expert oversight, but also effectively combines the rapid capabilities of AI with the depth of clinical knowledge. By drastically reducing trial preparation times from weeks to mere days, it significantly decreases the chances of amendments and mitigates overall risk, all while seamlessly fitting into existing workflows without the need for extensive retraining. With Aika, clinical trial teams can focus more on strategic decision-making rather than being bogged down by administrative tasks.
Description
HEKMA is a pioneering company utilizing artificial intelligence to enhance the efficiency of clinical trials by optimizing patient recruitment, assessing trial feasibility, and fostering patient engagement.
Their comprehensive platform caters to a diverse audience, including contract research organizations (CROs), pharmaceutical sponsors, healthcare facilities, and patients, by integrating electronic health records (EHRs) with AI-driven trial matching, clinical trial management solutions, and tools for engaging patients.
The core mission of HEKMA is to minimize delays in enrollment, broaden access to clinical trials—especially for underrepresented communities—and streamline the clinical research process to ensure it is more efficient, transparent, and centered around patient needs.
With a blend of healthcare knowledge, artificial intelligence capabilities, and clinical operations expertise, HEKMA adheres to crucial industry regulations such as HIPAA, 21 CFR Part 11, GDPR, and HL7/FHIR, ensuring the highest standards of compliance.
By harnessing innovative technology, HEKMA aims to transform the landscape of clinical trials, ultimately contributing to advancements in medical research and patient care.
API Access
Has API
API Access
Has API
Screenshots View All
No images available
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Biorce
Founded
2024
Country
Spain
Website
www.biorce.com/our-software
Vendor Details
Company Name
HEKMA
Founded
2018
Country
United States
Website
www.hekma.ai/
Product Features
Clinical Trial Management
21 CFR Part 11 Compliance
Document Management
Electronic Data Capture
Enrollment Management
HIPAA Compliant
Monitoring
Patient Database
Recruiting Management
Scheduling
Study Planning
Product Features
Clinical Trial Management
21 CFR Part 11 Compliance
Document Management
Electronic Data Capture
Enrollment Management
HIPAA Compliant
Monitoring
Patient Database
Recruiting Management
Scheduling
Study Planning